Latest News and Press Releases

Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Pediatric Cancer Biomarkers Market by Indication, Biomarker, End User, and Region" report has been added to ResearchAndMarkets.com's offering. This...

Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Oncology Based in-Vivo CRO - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...

Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Oncology Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offeringThe report provides access to deal...

Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Oncology Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering.Oncology Collaboration and Licensing...

KNOXVILLE, TN, March 12, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that the United States Patent and Trademark Office...

Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Pediatric Clinical Trials Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global pediatric clinical...

NEW YORK, N.Y. and MEMPHIS, Tenn., June 08, 2023 (GLOBE NEWSWIRE) -- The Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital announced a new pediatric-focused...

CRANBURY, N.J., June 01, 2023 (GLOBE NEWSWIRE) -- Physicians’ Education Resource, LLC (PER®), a top educational resource for health care professionals across all specialties to advance patient care,...

CRANBURY, N.J., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Physicians' Education Resource®, LLC (PER®), a top educational resource for health care professionals across all specialties to advance patient...

GUILFORD, Conn., April 25, 2022 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., an AI driven clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, today announced the...